News

Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its ...
Germain, in collaboration with Novotel, is delighted to unveil the Legendary Room celebrating Alain Roche at Novotel Valencia ...
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...
Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...
Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...
Zealand Pharma announces closing of collaboration and license agreement with Roche ...
As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...
The Prime Minister finally has a new chief science adviser, almost a year after his former adviser stepped down. Ministry of ...
The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.
A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...
Is Dot & Key as effective as La Roche-Posay sunscreen? Read this comparison guide and choose the best sunscreen brands to ...